These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3118638)

  • 1. Influence of carbon-dioxide tension and medium buffer concentration on medium pH and MIC values of erythromycin for Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923 in a micro-aerobic atmosphere.
    Andreasen JJ; Nissen B; Hartzen SH
    Acta Pathol Microbiol Immunol Scand B; 1987 Aug; 95(4):253-5. PubMed ID: 3118638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of carbon dioxide upon the in vitro activity of erythromycin.
    Dibb WL; Digranes A; Bottolfsen KL
    Acta Pathol Microbiol Immunol Scand B; 1986 Jun; 94(3):173-6. PubMed ID: 3090858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of environmental factors on the in vitro potency of azithromycin.
    Retsema JA; Brennan LA; Girard AE
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):834-42. PubMed ID: 1662627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pH on the activity of ceftizoxime.
    Uri JV
    Acta Microbiol Hung; 1984; 31(3):207-11. PubMed ID: 6097085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regression line for erythromycin is not valid for beta-hemolytic streptococci group A.
    Brorson JE; Larsson P
    Scand J Infect Dis; 1987; 19(2):243-6. PubMed ID: 3112935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of carbon dioxide on in vitro susceptibility of anaerobic bacteria to erythromycin.
    Goldstein EJ; Sutter VL; Kwok YY; Lewis RP; Finegold SM
    Antimicrob Agents Chemother; 1981 Dec; 20(6):705-8. PubMed ID: 6798927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-anaerobic activity of erythromycin, azithromycin and clarithromycin: effect of pH adjustment of media to compensate for pH shift caused by incubation in CO2.
    Ednie LM; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1998 Mar; 41(3):387-9. PubMed ID: 9578166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postexposure factors influencing the duration of postantibiotic effect: significance of temperature, pH, cations, and oxygen tension.
    Fuursted K
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1693-6. PubMed ID: 9257743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of carbon dioxide and pH on susceptibility of Bacteroides fragilis group to erythromycin.
    Hansen SL; Swomley P; Drusano G
    Antimicrob Agents Chemother; 1981 Feb; 19(2):335-6. PubMed ID: 6812492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility testing of 7 antibiotics against anaerobic bacteria: comparison of 2 different media and carbon dioxide concentrations.
    Jansen JE; Bremmelgaard A
    Acta Pathol Microbiol Immunol Scand B; 1987 Feb; 95(1):65-73. PubMed ID: 3105247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant prevention concentration of nalidixic acid, ciprofloxacin, clinafloxacin, levofloxacin, norfloxacin, ofloxacin, sparfloxacin or trovafloxacin for Escherichia coli under different growth conditions.
    Linde HJ; Lehn N
    J Antimicrob Chemother; 2004 Feb; 53(2):252-7. PubMed ID: 14688048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminished effect of gentamicin under anaerobic or hypercapnic conditions.
    Reynolds AV; Hamilton-Miller JM; Brumfitt W
    Lancet; 1976 Feb; 1(7957):447-9. PubMed ID: 55718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of carbon dioxide on the in vitro activity of erythromycin and RU-28965 against anaerobic bacteria.
    Felmingham D; Robbins MJ; Marais R; Ridgway GL; Gruneberg RN
    Drugs Exp Clin Res; 1987; 13(4):195-9. PubMed ID: 3113907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pH, inoculum size, and incubation time on the susceptibility of Ureaplasma urealyticum to erythromycin in vitro.
    Kenny GE; Cartwright FD
    Clin Infect Dis; 1993 Aug; 17 Suppl 1():S215-8. PubMed ID: 8399919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum.
    Pruul H; McDonald PJ
    Antimicrob Agents Chemother; 1992 Jan; 36(1):10-6. PubMed ID: 1317141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of culture medium and carbon dioxide concentration on growth of anaerobic bacteria and medium pH.
    Jansen JE; Bremmelgaard A
    Acta Pathol Microbiol Immunol Scand B; 1986 Oct; 94(5):319-23. PubMed ID: 3098041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group.
    Barry AL; Thornsberry C; Gavan TL
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):544-9. PubMed ID: 2548865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpretive criteria and quality control for antimicrobial susceptibility tests of levofloxacin.
    Barry A; Fuchs P; Tenover F; Allen S; Hardy D; Jorgensen J; McLaughlin J; Reller L
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):822-6. PubMed ID: 7889952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro postantibiotic effects of miocamycin and erythromycin on gram-positive cocci.
    Varotto F; Garlaschi ML; Garlaschi MC; Falchi M; Scaglione F; Cattaneo G; De Luca M; Fraschini F
    J Chemother; 1990 Dec; 2(6):355-61. PubMed ID: 2093106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.